CHAMPIONS ONCOLOGY, INC. (CSBR)
$4.96-$0.09 (-1.79%) Today
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
https://www.championsoncology.comSEC filings for CSBR on EDGAR
No Form 4 activity for CSBR in the last 90 days.
13 Form 4 filings on record, the earliest from Nov 1, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert Lawrence Brainin - Director | Grant or award | Option to purchase Common Stock | 9,901 | $10.10 | $100K | |
| Robert Lawrence Brainin - Director | Grant or award | Option to purchase Common Stock | 14,130 | $7.00 | $99K | |
| Robert Lawrence Brainin - Director | Grant or award | Option to purchase Common Stock | 19,070 | $5.51 | $105K | |
| Robert Lawrence Brainin - Director | Grant or award | Option to purchase Common Stock | 23,030 | $4.64 | $107K | |
| Joel Ackerman - Director | Grant or award | Option to purchase Common Stock | 21,216 | $6.80 | $144K | |
| Philip P. Breitfeld - Director | Grant or award | Option to purchase Common Stock | 13,790 | $6.80 | $94K | |
| David Sidransky - Director | Grant or award | Option to purchase Common Stock | 21,216 | $6.80 | $144K | |
| Daniel Newman Mendelson - Director | Grant or award | Option to purchase Common Stock | 13,790 | $6.80 | $94K | |
| Scott R. Tobin - Director | Grant or award | Option to purchase Common Stock | 25,460 | $6.80 | $173K | |
| Joel Ackerman - Director | Option exercise | Common Stock | 94,405 | $2.10 | $198K | |
| Joel Ackerman - Director | Option exercise | Option to purchase Common Stock | 94,405 | $2.10 | $198K | |
| Scott R. Tobin - Director | Grant or award | Option to purchase Common Stock | 34,550 | $4.64 | $160K | |
| Philip P. Breitfeld - Director | Grant or award | Option to purchase Common Stock | 18,715 | $4.64 | $87K | |
| Daniel Newman Mendelson - Director | Grant or award | Option to purchase Common Stock | 21,590 | $4.64 | $100K | |
| David Sidransky - Director | Grant or award | Option to purchase Common Stock | 21,880 | $4.64 | $102K | |
| Joel Ackerman - Director | Grant or award | Option to purchase Common Stock | 43,190 | $4.64 | $200K | |
| Joel Ackerman - Director | Option exercise | Common Stock | 88,470 | $2.10 | $186K | |
| Joel Ackerman - Director | Option exercise | Common Stock | 16,667 | $5.43 | $91K | |
| Joel Ackerman - Director | Option exercise | Option to purchase Common Stock | 88,470 | $2.10 | $186K | |
| Joel Ackerman - Director | Option exercise | Option to purchase Common Stock | 16,667 | $5.43 | $91K |
CHAMPIONS ONCOLOGY, INC. (CSBR) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-01-30. The full record for CSBR runs to 13 Form 4 filings, the earliest from 2024-11-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CSBR were filed in the last 90 days.
No insider sales of CSBR were filed in the last 90 days.
This page tracks CSBR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CSBR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
